A生物醫(yī)藥產(chǎn)業(yè)基金投資管理有限公司投資策略分析.pdf

1、In 2010, biological medicine industry was identified as strategic new industry.Inthe future, China's biological medicine industry will face rapid development.Industrylayout and adjustment will meet great opportunity.At p

2、resent, China's biologicalmedicine industry development salient features are: Biological medicine industry inits early, large investment and cycle is long, the risk is high.It need outside capitalsupport.At the same time

3、 the existing loans financing, equity financing, mergersrestructuring and can't meet the way the development of biological medicine industryneeds.So, as a kind of new financing tools development biological medicine indus

4、tryfunds have great practical significance.
　　This paper from the macro environment analysis.Through to the biologicalmedicine industry and market detailed analysis, find A company investmentopportunities and threats.

5、Then, on A company internal environment are analyzed andsummarized the advantages and disadvantages of company A.Finally, Combined with4 M pattern on the screening of investment projects and by A company for external,int